Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine for Sleep and Cognition in Depression
NCT00520507Phase 4Completed
- Sponsor
- Queen's University
- Start
- Oct 2007
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of olanzapine in major depressive disorder (MDD), bipolar disorder (BD), sponsored by Queen's University. Started Oct 2007; status: completed.
02
Drugs
olanzapine
03
Conditions
major depressive disorder (MDD)bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00520507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00520507.